Milestone Pharmaceuticals (MIST) announced that Express Scripts has added Cardamyst nasal spray to its commercial national formularies, effective March 2.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MIST:
- Regulatory Disruptions Pose Material Operational Risks for Milestone Pharmaceuticals
- Milestone: Early CARDAMYST Launch Progress and Solid Cash Position Underscore Buy Rating and $8 Target
- Midday Fly By: FedEx reports ‘beat and raise,’ Ecolab to acquire CoolIT
- Milestone Advances CARDAMYST Launch After Landmark PSVT Approval and Bolsters Cash Runway
- Morning Movers Ecolab lower after $4.75B deal to acquire CoolIT Systems